Product image of Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm (Montelukast) supplied by GNH India

Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm

Active Ingredient:
Montelukast
Origin:
EU

Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm (Montelukast)

Montelukast, the active ingredient in Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm, is a leukotriene receptor antagonist presented as an oral formulation for pediatric use. It is used to prevent asthma symptoms and manage allergic rhinitis in children aged six months to five years.

GNH India supplies Montelucaste Para Crianças Com Idades Compreendidas Entre 6 Meses E 5 Anos De Idade Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ratiopharm-Comercio E Industria De Produtos Farmaceuticos Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montelukast acts on the leukotriene pathway to control chronic respiratory and allergic conditions in children.

  • Asthma: prevention of chronic asthma symptoms and reduction of exacerbations in children 6 months–5 years.
  • Allergic rhinitis: relief of nasal congestion, sneezing and itching associated with pediatric allergic rhinitis.

How It Works

  • Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1, preventing leukotriene D4 and related mediators from binding. This inhibition reduces bronchoconstriction, vascular permeability, and inflammatory cell recruitment in the airways, thereby improving respiratory function and decreasing allergic inflammation.

Side Effects

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Abdominal pain: occasional discomfort.
  • Cough: transient irritation.
  • Sore throat: mild irritation of the pharynx.
  • Fever: low‑grade temperature elevation.
  • Nausea: occasional upset stomach.

Serious or Rare Side Effects

  • Allergic reactions: rash, angioedema, or anaphylaxis.
  • Neuropsychiatric events: agitation, depression, or suicidal thoughts.
  • Liver enzyme elevation: signs of hepatic dysfunction.
  • Neutropenia: reduced white‑blood‑cell count.
  • Severe hypersensitivity: bronchospasm or swelling of the face and throat.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Neuropsychiatric monitoring: observe for mood changes, agitation, or depression.
  • Hepatic function: assess baseline liver enzymes in patients with liver disease.
  • Severe asthma caution: not a rescue medication; ensure appropriate rescue inhaler is available.
  • Hypersensitivity: avoid in patients with known allergy to montelukast or excipients.
  • Store at room temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Montelukast may interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Rifampin: induces metabolism, reducing montelukast efficacy.
  • Ketoconazole: inhibits metabolism, potentially increasing drug levels.
  • Phenobarbital: induces metabolism, lowering therapeutic effect.

Moderate Interactions (Monitor Closely)

  • Beta‑agonists: additive bronchodilation may enhance respiratory relief.
  • NSAIDs: may increase risk of cutaneous reactions.
  • Warfarin: monitor INR as montelukast can affect anticoagulation control.

Frequently Asked Questions

Montelucaste Para Crianças contains montelukast, a leukotriene receptor antagonist that is prescribed to prevent chronic asthma symptoms and to manage allergic rhinitis in children from six months up to five years of age.

Montelukast blocks the cysteinyl leukotriene receptor CysLT1, stopping leukotriene D4 and related mediators from causing bronchoconstriction, airway swelling, and inflammation, which helps keep the airways open and reduces allergic responses.

The appropriate dose is determined by the prescribing clinician based on the child’s age, weight, and clinical condition. Parents should follow the healthcare professional’s instructions and not adjust the dose on their own.

Safety data for montelukast in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk, and the decision must be made by a qualified healthcare provider.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast is an oral leukotriene antagonist, whereas inhaled corticosteroids are anti‑inflammatory agents delivered directly to the lungs. Montelukast is often used as an add‑on therapy or for patients who cannot tolerate inhaled steroids, but it does not replace the anti‑inflammatory effect of corticosteroids in severe asthma.

Store Montelucaste Para Crianças at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

The medication is taken orally, usually as a chewable tablet or oral granule, once daily in the evening as directed by the prescriber. It should be swallowed or mixed with a small amount of food or liquid according to the specific product instructions.

Serious concerns include rare neuropsychiatric events such as depression, agitation, or suicidal thoughts, as well as severe allergic reactions like anaphylaxis. Any sudden mood changes or signs of an allergic response require immediate medical attention.

Children with a known hypersensitivity to montelukast, any of its excipients, or a history of severe allergic reactions to leukotriene‑modifying agents should avoid this medication. It is also not intended for acute asthma attacks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Montelukast

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT